Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinglei Qu

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Journal of Clinical Pathology|November 4, 2011
Receptor activator for nuclear factor κ B expression predicts poor prognosis in breast cancer patients with bone metastasis but not in patients with visceral metastasisLingyun Zhang, Yuee Teng, Ye Zhang, et al.
Oncology Letters|June 29, 2012
C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathwayLingyun Zhang, Yuee Teng, Ye Zhang, et al.
Annals of Surgical Oncology|May 16, 2019
Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer PrognosisYibo Fan, Xiaofang Che, Jinglei Qu, et al.
American Journal of Cancer Research|January 8, 2021
Prediction of KRAS, NRAS and BRAF status in colorectal cancer patients with liver metastasis using a deep artificial neural network based on radiomics and semantic featuresRuichuan Shi, Weixing Chen, Bowen Yang, et al.
Translational Oncology|June 9, 2016
A Prognostic Model in Metastatic or Recurrent Gastric Cancer Patients with Good Performance Status Who Received First-Line ChemotherapyJin Wang, Jinglei Qu, Zhi Li, et al.
BMC Cancer|November 9, 2018
The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patientsPing Yu, Mingyi Zhou, Jinglei Qu, et al.
Biomarkers in Medicine|October 27, 2017
Combination of platelet count and neutrophil-lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival in metastatic advanced gastric cancerJin Wang, Jinglei Qu, Zhi Li, et al.
Oncotarget|August 6, 2016
MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cellsQian Dong, Ce Li, Xiaofang Che, et al.
Frontiers in Oncology|March 19, 2021
A Prognostic Nomogram of Colon Cancer With Liver Metastasis: A Study of the US SEER Database and a Chinese CohortChuan Liu, Chuan Hu, Jiale Huang, et al.
Annals of Translational Medicine|May 2, 2020
Nomogram-based prediction of survival in unresectable or metastatic gastric cancer patients with good performance status who received first-line chemotherapyJin Wang, Bowen Yang, Zhi Li, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pathology|November 4, 2011
Receptor activator for nuclear factor κ B expression predicts poor prognosis in breast cancer patients with bone metastasis but not in patients with visceral metastasisLingyun Zhang, Yuee Teng, Ye Zhang, et al.
Oncology Letters|June 29, 2012
C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathwayLingyun Zhang, Yuee Teng, Ye Zhang, et al.
Annals of Surgical Oncology|May 16, 2019
Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer PrognosisYibo Fan, Xiaofang Che, Jinglei Qu, et al.
American Journal of Cancer Research|January 8, 2021
Prediction of KRAS, NRAS and BRAF status in colorectal cancer patients with liver metastasis using a deep artificial neural network based on radiomics and semantic featuresRuichuan Shi, Weixing Chen, Bowen Yang, et al.
Translational Oncology|June 9, 2016
A Prognostic Model in Metastatic or Recurrent Gastric Cancer Patients with Good Performance Status Who Received First-Line ChemotherapyJin Wang, Jinglei Qu, Zhi Li, et al.
BMC Cancer|November 9, 2018
The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patientsPing Yu, Mingyi Zhou, Jinglei Qu, et al.
Biomarkers in Medicine|October 27, 2017
Combination of platelet count and neutrophil-lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival in metastatic advanced gastric cancerJin Wang, Jinglei Qu, Zhi Li, et al.
Oncotarget|August 6, 2016
MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cellsQian Dong, Ce Li, Xiaofang Che, et al.
Frontiers in Oncology|March 19, 2021
A Prognostic Nomogram of Colon Cancer With Liver Metastasis: A Study of the US SEER Database and a Chinese CohortChuan Liu, Chuan Hu, Jiale Huang, et al.
Annals of Translational Medicine|May 2, 2020
Nomogram-based prediction of survival in unresectable or metastatic gastric cancer patients with good performance status who received first-line chemotherapyJin Wang, Bowen Yang, Zhi Li, et al.
Pageof 6